Ixekizumab is superior to placebo for the treatment of nail, scalp, and palmoplantar psoriasis in pediatric patients with moderate to severe plaque psoriasis

被引：0
|
作者：
Paller, Amy S. [1 ]
Magarinos, Gabriel Alejandro [1 ]
Pinter, Andreas [1 ]
Cather, Jennifer [1 ]
Keller, Stuart [1 ]
Capriles, Claudia Rodriguez [1 ]
Gallo, Gaia [1 ]
Edson-Heredia, Emily [1 ]
Li, Lingnan [1 ]
Papp, Kim [1 ]
机构：
[1] Northwestern Med, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
14161
引用
收藏
页码：AB20 / AB20
页数：1
相关论文
共 50 条
  • [41] Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis
    Li, Wendy
    Ghamrawi, Rima
    Haidari, Wasim
    Feldman, Steven R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (04) : 380 - 387
  • [42] Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
    Libon, Florence
    Lebas, Eve
    De Schaetzen, Virginie
    Sabatiello, Murielle
    De Schepper, Sofie
    Nikkels, Arjen F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 947 - 955
  • [43] Efalizumab for the treatment of moderate to severe plaque psoriasis
    Jordan, JK
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1476 - 1482
  • [44] Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
    Hannah A. Blair
    Pediatric Drugs, 2021, 23 : 601 - 608
  • [45] Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
    Blair, Hannah A.
    PEDIATRIC DRUGS, 2021, 23 (06) : 601 - 608
  • [46] Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
    Giunta, Alessandro
    Ventura, Alessandra
    Chimenti, Maria Sole
    Bianchi, Luca
    Esposito, Maria
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1643 - 1651
  • [47] Impact of ixekizumab on palmoplantar plaque psoriasis compared to placebo and etanercept: results from UNCOVER 2
    Menter, A.
    Reich, K.
    Warren, R. B.
    Duffin, K. C.
    Langley, R.
    Kerr, L.
    Dennehy, E.
    Shrom, D. S.
    Amato, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S170 - S170
  • [48] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [49] Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus
    Langley, R. G.
    Saurat, J. H.
    Reich, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (03) : 373 - 381
  • [50] Successful treatment of moderate to severe plaque psoriasis of the scalp with clobetasol propionate spray, 0.05%
    Bolden, Fran E. Cook
    Goffe, Bernard S.
    Sofen, Howard L.
    Colon, Luz E.
    Gottschalk, Ronald W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB157 - AB157
12345